Related Experiment Video
Updated: May 17, 2025

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
Published on: August 11, 2018
Jelleine-I Membrane Interaction-related Biological Properties and Antimicrobial Activity against MDR, XDR, and
Adrielle Pieve de Castro1, Julio Cesar Moreira Brito2, Wanderson Aparecido Brandão Candido3
1Laboratório de Radioisótopos, Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Campus Pampulha, Belo Horizonte, Minas Gerais 31270-901, Brazil.
Abstract:
Emerging bacterial infections pose a serious threat to human health. Acinetobacter baumannii is a particular concern due to its antimicrobial resistance phenotypes, especially to carbapenems. In this context, antimicrobial peptides appear as a promising class. Jelleine-I is a peptide identified from the royal jelly from Apis mellifera bee, which has demonstrated significant antibacterial effects against various microorganisms. This study aimed to characterize the activity of jelleine-I against clinical isolates of A. baumannii resistant to carbapenems (CRAB) and with different resistance phenotypes, in addition to investigating the peptide-membrane interaction in biomimetic media. Microbiological assays with jelleine-I performed against A. baumannii with MIC values of 8-16 μM were observed. Biophysical studies on the bacterial mimetic membrane show a possible disruption of the organization of the phospholipid bilayer. The significant affinity promoted by entropic and enthalpic contributions suggests that the main antimicrobial action occurs on the bacterial membrane. In addition, the negligible hemolytic activity and toxicity against VERO and HaCaT cells reveal jelleine-I as a potential novel antimicrobial agent, especially against microorganisms that exhibit high and diverse antimicrobial resistance, such as A. baumannii.
Insights
Jelleine-I, an antimicrobial peptide from bee jelly, effectively combats carbapenem-resistant Acinetobacter baumannii. It disrupts bacterial membranes with low toxicity, showing promise as a novel antibacterial agent.
Area of Science:
- Microbiology
- Biochemistry
- Biophysics
Background:
- Emerging bacterial infections, particularly carbapenem-resistant Acinetobacter baumannii (CRAB), represent a significant global health threat.
- Antimicrobial peptides (AMPs) are emerging as a promising alternative to conventional antibiotics due to their unique mechanisms of action.
- Jelleine-I, an AMP derived from bee royal jelly, has shown broad-spectrum antibacterial activity.
Purpose of the Study:
- To evaluate the efficacy of jelleine-I against clinical isolates of CRAB.
- To investigate the interaction mechanism of jelleine-I with bacterial membranes.
- To assess the safety profile of jelleine-I regarding hemolytic activity and cytotoxicity.
Main Methods:
- Microbiological assays were conducted to determine the minimum inhibitory concentration (MIC) of jelleine-I against CRAB isolates.
- Biophysical techniques were employed to study the interaction between jelleine-I and biomimetic bacterial membranes.
- Hemolytic activity assays and cytotoxicity tests on VERO and HaCaT cells were performed.
Main Results:
- Jelleine-I exhibited significant antibacterial activity against CRAB isolates, with MIC values ranging from 8-16 μM.
- Biophysical studies indicated that jelleine-I disrupts the organization of phospholipid bilayers, suggesting membrane permeabilization as a key mechanism.
- Jelleine-I demonstrated negligible hemolytic activity and low toxicity towards mammalian cells.
Conclusions:
- Jelleine-I is a potent antimicrobial agent effective against multidrug-resistant Acinetobacter baumannii.
- The primary antimicrobial action of jelleine-I involves the disruption of the bacterial membrane.
- Jelleine-I represents a promising candidate for the development of novel therapeutics against challenging bacterial infections.
More Related Videos
11:17Monitoring Changes in Membrane Polarity, Membrane Integrity, and Intracellular Ion Concentrations in Streptococcus pneumoniae Using Fluorescent Dyes
Published on: February 17, 2014
11:56Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Combined Effects of Drugs: Synergism
Such synergistic combinations...